40 min
Seminar, Hosted by U.S. Food and Drug Administration
FDA Grand Rounds – Pharmacovigilance in Practice: From Safety Signals to Regulatory Action
LCDR Anne Tobenkin, Pharm.D., M.S. and Leah Herity, Pharm.D., M.P.H.
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Recording
Abstract
FDA safety evaluators explain how adverse-event information becomes a regulatory action. They review three recent safety findings to show how the agency identifies and investigates potential problems with marketed medicines.